11 min read

"Depression is caused by a chemical imbalance in the brain. Antidepressants correct this imbalance."

Chapter 17: The Chemical Imbalance Theory — Did Your Doctor Lie to You?

"Depression is caused by a chemical imbalance in the brain. Antidepressants correct this imbalance."

If you've ever been prescribed an antidepressant, there's a good chance you heard some version of this explanation — from your doctor, from the medication's informational materials, or from a well-meaning friend. The chemical imbalance theory has been the dominant popular explanation for depression for over thirty years. It's simple, destigmatizing, and feels scientifically authoritative.

In 2022, a major umbrella review by Joanna Moncrieff and colleagues, published in Molecular Psychiatry, made headlines around the world: "No evidence that depression is caused by low serotonin levels." The review systematically examined the evidence for the serotonin hypothesis of depression — the specific claim that depression is caused by low levels of, or reduced activity in, the serotonin system — and concluded that the evidence does not support it.

The response was explosive. Headlines ranged from "Everything You Were Told About Depression Was Wrong" to "The Chemical Imbalance Theory Is Dead." Social media debates erupted between people who felt vindicated ("I knew it was a lie!") and people who felt alarmed ("Does this mean my medication doesn't work?").

Both reactions were wrong — or at least dramatically oversimplified. This chapter navigates the complicated truth between "depression is a chemical imbalance" and "the chemical imbalance theory was a lie," because the real story is more interesting, more nuanced, and more practically important than either extreme.

Important: Nothing in this chapter should be interpreted as medical advice. If you are currently taking antidepressants, do not stop or change your medication based on this chapter. Any changes to medication should be made in consultation with your prescribing physician.

Before You Read: Confidence Check

Rate your confidence (1–10) that each statement is true.

  1. "Depression is caused by a chemical imbalance — specifically low serotonin." ___
  2. "Antidepressants work by correcting the serotonin imbalance." ___
  3. "The Moncrieff review proved that antidepressants don't work." ___
  4. "If the chemical imbalance theory is wrong, it means depression is 'all in your head.'" ___
  5. "Doctors who told patients about chemical imbalances were lying." ___

The Serotonin Hypothesis: What It Claimed

The serotonin hypothesis of depression, which emerged in the 1960s–1980s, proposed that depression is caused by deficient activity in the brain's serotonin system. The hypothesis was based on several observations:

The drug connection. Drugs that increase serotonin availability in the brain (first tricyclic antidepressants, then SSRIs — Selective Serotonin Reuptake Inhibitors) appeared to improve depression symptoms. If boosting serotonin helps depression, the reasoning went, then depression must be caused by insufficient serotonin.

The depletion studies. Some (but not all) studies found that artificially depleting serotonin in healthy volunteers produced depressive symptoms in some people — suggesting a causal role for serotonin.

The metabolite studies. Some studies measured serotonin metabolites (breakdown products) in the cerebrospinal fluid of depressed patients and found lower levels compared to non-depressed controls.

This evidence was suggestive but not definitive. The hypothesis was always a simplification — serotonin researchers themselves acknowledged significant uncertainties. But the simplification was useful: it gave doctors an explanation to offer patients, it reduced stigma (depression is a brain disease, not a character flaw), and it made sense of why the medications seemed to work.


The Moncrieff Review: What It Actually Found

In July 2022, Moncrieff, Cooper, Stockmann, et al. published "The serotonin theory of depression: A systematic umbrella review of the evidence" in Molecular Psychiatry. The review examined the evidence across six domains:

  1. Serotonin levels. No consistent evidence that depressed people have lower serotonin levels or activity.
  2. Serotonin receptors. No consistent evidence that depressed people have altered serotonin receptor levels.
  3. Serotonin transporter. Some evidence that higher serotonin transporter activity (which would reduce serotonin availability) is associated with depression — but this could be an effect of depression rather than a cause.
  4. Tryptophan depletion. Studies that artificially reduce serotonin (by depleting its precursor, tryptophan) do not reliably produce depression in most healthy volunteers.
  5. The serotonin transporter gene. The famous 5-HTTLPR gene variant, once thought to make people more vulnerable to depression, was not confirmed by large-scale studies.
  6. Serotonin levels in depressed patients. Some evidence of elevated (not reduced) serotonin activity in some depressed patients — the opposite of what the hypothesis predicts.

The conclusion: "The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations."

What the Review Did NOT Say

This is where the popular coverage went wrong. The Moncrieff review did NOT conclude:

  • That antidepressants don't work. The review was about the mechanism (whether low serotonin causes depression), not about the treatment effect (whether SSRIs help depressed people). These are different questions. A drug can work without the original theory about its mechanism being correct. Aspirin reduces fever, but not because fever is caused by an "aspirin deficiency."

  • That depression isn't a real biological condition. The review concluded that the specific serotonin hypothesis is not supported. Depression almost certainly involves biological factors — but the specific "low serotonin" story is too simple.

  • That doctors were lying. Most doctors who explained depression as a "chemical imbalance" were communicating what they understood to be the best available explanation. The serotonin hypothesis was widely taught in medical schools and was the consensus framework for decades. It was wrong, but communicating it was not dishonest.


Why the Chemical Imbalance Framing Was Useful (and Harmful)

Why It Was Useful

Destigmatization. "Your depression is a chemical imbalance, like diabetes is an insulin imbalance" gave millions of people permission to seek treatment without shame. The biological framing reduced the sense that depression was a personal weakness or moral failure. This was genuinely helpful.

Treatment adherence. The chemical imbalance framing made medication feel logical. "Your brain doesn't have enough serotonin, and this pill increases it" is a clean narrative that motivates compliance.

Accessibility. The explanation is simple enough for a busy doctor to convey in a five-minute appointment. Whether it's accurate is a separate question from whether it's communicable.

Why It Was Harmful

It was wrong. The serotonin hypothesis, as commonly stated, is not supported by the evidence. Communicating an incorrect causal model — even for good reasons — is problematic because it shapes how people understand their condition and make decisions about treatment.

It oversimplified depression. By reducing depression to a single neurotransmitter, the chemical imbalance model obscured the roles of psychological factors (cognitive patterns, learning history, relationship quality), social factors (poverty, discrimination, isolation), and behavioral factors (exercise, sleep, substance use). A person told "your depression is a chemical imbalance" may not explore these other contributing factors.

It may have discouraged non-pharmaceutical approaches. If depression is "just chemistry," then the solution is chemical (medication). This framing may have reduced interest in therapy (which is at least as effective as medication for mild to moderate depression) and lifestyle factors (exercise, sleep, social connection — all of which have evidence for depression).

It created vulnerability to backlash. Because the framing was too certain ("we know depression is caused by..."), its undermining creates a vulnerable overcorrection: "If the chemical imbalance theory is wrong, does that mean depression isn't real? Does that mean my medication is a lie?" These overcorrections are harmful — and they're a predictable consequence of communicating oversimplified science with unwarranted certainty.


Do Antidepressants Work?

This is the question that matters most for people currently taking or considering antidepressants, and the answer is: yes, but with important caveats.

The Evidence For Effectiveness

Meta-analyses consistently show that SSRIs are more effective than placebo for moderate to severe depression. The most comprehensive meta-analysis — Cipriani et al. (2018), published in The Lancet, analyzing 522 trials and over 116,000 participants — found that all 21 antidepressants studied were more effective than placebo. This is robust evidence.

The effect size is moderate. Antidepressants reduce depression symptoms by approximately 2 points on the Hamilton Rating Scale for Depression compared to placebo. Whether this is clinically meaningful is debated — some argue it is; others argue it's modest. For severe depression, the effect size is larger.

Individual response varies. Some people respond dramatically to antidepressants. Others don't respond at all. Current science cannot reliably predict who will respond to which medication.

The Caveats

The placebo response is large. Approximately 30–40% of depressed patients improve on placebo. This doesn't mean depression is "imagined" — the placebo response involves real neurobiological changes. But it means that a significant portion of improvement attributed to medication may be due to non-specific factors (hope, therapeutic relationship, natural recovery).

For mild depression, the advantage over placebo is small. The greatest drug-placebo difference is seen in severe depression. For mild depression, the difference may not be clinically significant. This suggests therapy and lifestyle interventions may be more appropriate first-line treatments for mild cases.

We don't fully understand the mechanism. SSRIs increase serotonin availability within hours, but the therapeutic effect takes 4–6 weeks. This delay suggests that the mechanism is more complex than simply "restoring serotonin levels." Current theories focus on neuroplasticity, neural circuit remodeling, and downstream effects that take weeks to develop.

Side effects are real. SSRIs can cause sexual dysfunction, weight gain, emotional blunting, gastrointestinal symptoms, and withdrawal effects upon discontinuation. These should be weighed against the benefits.


The Nuanced Truth

Here is what the evidence supports, stated as precisely as possible:

Depression is not simply "caused by low serotonin." The chemical imbalance framing, as commonly communicated to patients and the public, is not supported by the evidence. Depression is a complex condition involving multiple biological, psychological, and social factors.

Antidepressants do help many people with depression. The evidence for their effectiveness, particularly for moderate to severe depression, is robust. The mechanism is more complex than "correcting a chemical imbalance."

The chemical imbalance theory was a useful simplification that became a harmful dogma. It served important purposes (destigmatization, treatment adherence) but also oversimplified depression in ways that limited understanding and treatment.

The correct response to the Moncrieff review is NOT to stop taking medication. It is to update our understanding of depression's causes while continuing to use treatments that work — and to expand the treatment conversation beyond medication to include therapy, exercise, sleep, social connection, and addressing life circumstances.

The harmful oversimplification runs both ways: - "Depression is just a chemical imbalance" — oversimplifies the cause - "The chemical imbalance theory was a lie, so antidepressants are useless" — oversimplifies the correction - Both versions sacrifice nuance for drama. The truth requires holding two ideas simultaneously: the theory was wrong AND the medications work, through mechanisms we don't fully understand.

Verdict: "Depression is caused by a chemical imbalance — specifically low serotonin" ⚠️ OVERSIMPLIFIED — The serotonin hypothesis of depression is not supported by the evidence (Moncrieff et al., 2022). Depression involves biological, psychological, and social factors. The "chemical imbalance" framing was a useful destigmatization tool that overstated the certainty and specificity of the causal model. Origin: Emerged from 1960s–80s pharmacological observations. The umbrella review (Moncrieff et al., 2022) found no consistent evidence across six domains. The framing was widely communicated by pharmaceutical marketing, medical education, and public health campaigns.

Verdict: "The Moncrieff review proved that antidepressants don't work"DEBUNKED — The review examined the serotonin theory of depression's cause, not whether SSRIs are effective treatments. Cipriani et al. (2018) meta-analysis of 522 trials found all 21 antidepressants studied outperformed placebo. A drug can work without the original theory about its mechanism being correct.

Verdict: "If the chemical imbalance theory is wrong, depression isn't a real biological condition"DEBUNKED — The failure of one specific theory (low serotonin) does not mean depression has no biological components. Depression almost certainly involves biological factors — they're just more complex than a single neurotransmitter imbalance. Genetics, inflammation, stress hormones, neural circuits, and neuroplasticity are all under active investigation.


Fact-Check Portfolio: Chapter 17

If any of your 10 claims involve depression causes, medication, or brain chemistry: - Does the claim present depression as having a single cause? - Does the claim conflate "the theory of the mechanism is wrong" with "the treatment doesn't work"? - Does the claim acknowledge the complexity of depression (biological + psychological + social)? - Does the claim account for both the strengths and limitations of medication?


After Reading: Confidence Revisited

  1. "Depression is caused by low serotonin." — What did the Moncrieff review find?
  2. "Antidepressants work by correcting the imbalance." — Can a drug work even if the original theory about its mechanism is wrong?
  3. "The Moncrieff review proved antidepressants don't work." — What was the review actually about?
  4. "If the chemical imbalance theory is wrong, depression is 'all in your head.'" — What does "all in your head" miss about biopsychosocial models?
  5. "Doctors who told patients about chemical imbalances were lying." — What's the difference between communicating an oversimplified model and lying?